Naloxone training gains traction as opioid risks reach dogs

Dogs can overdose on opioids, too, and a growing body of veterinary and public health guidance says naloxone can be a lifesaving first response for canine patients after suspected exposure. The latest coverage in veterinary media builds on existing guidance from FDA, university clinicians, and poison center data showing that dogs, especially those that sniff or ingest powdered drugs, can develop the same opioid toxidrome seen in people: sedation, collapse, shallow breathing, bradycardia, and loss of consciousness. FDA specifically warns that pets can overdose on fentanyl and other opioids, with working dogs at particular risk, while Ohio State emergency veterinarian Edward Cooper, VMD, MS, DACVECC, says naloxone can reverse opioid effects in dogs within two to three minutes, though repeat dosing may be needed. (fda.gov)

Why it matters: For veterinary professionals, this is moving from niche toxicology knowledge to practical client education and emergency preparedness. FDA advises veterinarians to counsel pet parents on locking up opioid medications and knowing what to do if a dog is exposed. Evidence also suggests training works: a 2020 JAAHA study on law enforcement K9 handlers found that targeted naloxone instruction improved confidence in recognizing overdose signs and administering intranasal or intramuscular naloxone. More recent poison center research, summarized in the Journal of Addiction Medicine, reports suspected illicit fentanyl exposures in both dogs and cats in the U.S. and Canada, with intranasal naloxone having been used successfully in veterinary medicine. (fda.gov)

What to watch: Expect more emphasis on take-home counseling, repeat-dose planning, and differential diagnosis as fentanyl exposures intersect with non-opioid adulterants such as xylazine or medetomidine, which naloxone does not reverse. (wcvmtoday.usask.ca)